These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20581673)

  • 1. How to stem the tide of carbapenemase-producing enterobacteriaceae?: proactive versus reactive strategies.
    Bilavsky E; Schwaber MJ; Carmeli Y
    Curr Opin Infect Dis; 2010 Aug; 23(4):327-31. PubMed ID: 20581673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.
    Gupta N; Limbago BM; Patel JB; Kallen AJ
    Clin Infect Dis; 2011 Jul; 53(1):60-7. PubMed ID: 21653305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings.
    Savard P; Perl TM
    Curr Opin Infect Dis; 2012 Aug; 25(4):371-7. PubMed ID: 22766646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.
    Friedman ND; Carmeli Y; Walton AL; Schwaber MJ
    Infect Control Hosp Epidemiol; 2017 May; 38(5):580-594. PubMed ID: 28294079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):256-60. PubMed ID: 19300408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology and clinical implications of carbapenemase-producing bacteria in Switzerland].
    Abbas M; Cherkaoui A; Fankhauser C; Schrenzel J; Harbarth S
    Rev Med Suisse; 2012 Apr; 8(338):882-4, 886-9. PubMed ID: 22611624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.
    Carmeli Y; Akova M; Cornaglia G; Daikos GL; Garau J; Harbarth S; Rossolini GM; Souli M; Giamarellou H
    Clin Microbiol Infect; 2010 Feb; 16(2):102-11. PubMed ID: 20085604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region.
    Pfeiffer CD; Cunningham MC; Poissant T; Furuno JP; Townes JM; Leitz A; Thomas A; Buser GL; Arao RF; Beldavs ZG
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):356-61. PubMed ID: 24602939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.
    Calfee DP
    J Infus Nurs; 2010; 33(3):150-4. PubMed ID: 20442598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit.
    Maragakis LL
    Crit Care Med; 2010 Aug; 38(8 Suppl):S345-51. PubMed ID: 20647792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose.
    Savard P; Perl TM
    Clin Microbiol Infect; 2014 Sep; 20(9):854-61. PubMed ID: 24980472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [KPC carbapenemases: what is at stake in clinical microbiology?].
    Cuzon G; Naas T; Nordmann P
    Pathol Biol (Paris); 2010 Feb; 58(1):39-45. PubMed ID: 19854586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging threat from carbapenem-resistant enterobacteriaceae.
    Landry J; Hurst H
    Nurs Womens Health; 2013 Dec; 17(6):519-24. PubMed ID: 24589052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.
    Lee BY; Bartsch SM; Wong KF; McKinnell JA; Slayton RB; Miller LG; Cao C; Kim DS; Kallen AJ; Jernigan JA; Huang SS
    Am J Epidemiol; 2016 Mar; 183(5):471-9. PubMed ID: 26861238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
    Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H
    Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area.
    Cheng VC; Chan JF; Wong SC; Chen JH; Tai JW; Yan MK; Kwan GS; Tse H; To KK; Ho PL; Yuen KY
    Chin Med J (Engl); 2013 Dec; 126(23):4504-9. PubMed ID: 24286415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-spectrum beta-lactamases: a challenge for clinical microbiologists and infection control specialists.
    Colodner R
    Am J Infect Control; 2005 Mar; 33(2):104-7. PubMed ID: 15761410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carbapenemase-producing enterobacteriae: epidemiology, strategies to control their spread and issues].
    Lepelletier D; Batard E; Berthelot P; Zahar JR; Lucet JC; Fournier S; Jarlier V; Grandbastien B
    Rev Med Interne; 2015 Jul; 36(7):474-9. PubMed ID: 25600328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiresistant Enterobacteriaceae: new threat of an old problem.
    Pitout JD
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):657-69. PubMed ID: 18847404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of an infection control programme to limit the spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a Belgian university hospital.
    Christiaens G; Barbier C; Warnotte J; Mutsers J
    J Hosp Infect; 2008 Apr; 68(4):366-7. PubMed ID: 18329138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.